SEC 13F Intelligence

Concorde Financial Corp / ABBV

Concorde Financial Corp’s Abbvie Inc Position

Does Concorde Financial Corp own Abbvie Inc (ABBV)? Yes27.2K shares worth $6M (+4.64% of its 13F portfolio) as of Q1 2026, down from 31.2K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
27.2K
% of Portfolio
+4.64%
Quarters Held
18
currently held

Position History ABBV

Reported value by quarter
Q4 ’21: $6MQ4 ’21Q1 ’22: $7MQ2 ’22: $6MQ3 ’22: $6MQ3 ’22Q4 ’22: $6MQ1 ’23: $7MQ2 ’23: $5MQ2 ’23Q3 ’23: $998,702Q4 ’23: $6MQ1 ’24: $8MQ1 ’24Q2 ’24: $6MQ3 ’24: $6MQ4 ’24: $6MQ4 ’24Q1 ’25: $7MQ2 ’25: $6MQ3 ’25: $7MQ3 ’25Q4 ’25: $7MQ1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202627.2K$6M+4.64%
Q4 202531.2K$7M+5.46%
Q3 202531.8K$7M+4.08%
Q2 202532.7K$6M+3.59%
Q1 202532.8K$7M+3.79%
Q4 202432.9K$6M+3.48%
Q3 202432.8K$6M+3.81%
Q2 202433.2K$6M+3.74%
Q1 202441.4K$8M+6.86%
Q4 202341.5K$6M+4.40%
Q3 20236.7K$998,702+1.70%
Q2 202340.7K$5M+3.59%
Q1 202341.3K$7M+4.80%
Q4 202241.9K$6M+3.79%
Q3 202241.9K$6M+3.79%
Q2 202242.0K$6M+7.18%
Q1 202245.6K$7M+4.17%
Q4 202146.8K$6M+3.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Concorde Financial Corp’s full portfolio or all institutional holders of ABBV.